Nomura Asset Management Co. Ltd. lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 971,591 shares of the biopharmaceutical company’s stock after acquiring an additional 59,486 shares during […]
StockNews.com upgraded shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from a buy rating to a strong-buy rating in a research note released on Thursday morning. A number of other brokerages also recently issued reports on BMY. BMO Capital Markets cut their price objective on Bristol-Myers Squibb from $55.00 to $48.00 and set a market […]
Advisory Services Network LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.9% in the fourth quarter, HoldingsChannel reports. The firm owned 81,260 shares of the biopharmaceutical company’s stock after selling 26,910 shares during the quarter. Advisory Services Network LLC’s holdings in Bristol-Myers Squibb were worth $4,169,000 as of its […]
Johnson Financial Group Inc. reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 46.3% during the 4th quarter, HoldingsChannel reports. The firm owned 6,183 shares of the biopharmaceutical company’s stock after selling 5,321 shares during the quarter. Johnson Financial Group Inc.’s holdings in Bristol-Myers Squibb were worth $317,000 at the end […]
Intech Investment Management LLC cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 42.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 389,875 shares of the biopharmaceutical company’s stock after selling 283,629 shares during the period. Intech Investment […]